Premium Nahrungsergänzungsmittel | artgerecht

Immunophenotyping – Definition and Clinical Use

Immunophenotyping is a diagnostic method that identifies and classifies immune cells based on their surface markers. It is primarily used in the diagnosis of blood cancers and immune disorders.

Regular tips about health Regular tips about health

Things worth knowing about "Immunophenotyping"

Immunophenotyping is a diagnostic method that identifies and classifies immune cells based on their surface markers. It is primarily used in the diagnosis of blood cancers and immune disorders.

What is Immunophenotyping?

Immunophenotyping is a laboratory diagnostic technique used to identify and classify immune cells based on the specific protein molecules they express on their surfaces. These surface proteins are known as CD antigens (Cluster of Differentiation markers) and serve as distinguishing features for different cell types, maturation stages, and activation states.

The method is most commonly performed using flow cytometry, a technology in which cells are passed individually through a laser beam and analyzed based on their fluorescence and light-scattering properties.

Clinical Applications

Immunophenotyping is applied across a wide range of medical specialties:

Hematology and Oncology: Diagnosis and classification of leukemias, lymphomas, and other blood cancers.
Immunology: Assessment of immune deficiencies, such as monitoring CD4 cell counts in HIV-infected patients or diagnosing congenital immunodeficiencies.
Transplant Medicine: Monitoring immune status before and after organ or stem cell transplantation.
Autoimmune Diseases: Analysis of immune cell populations for diagnosis and disease monitoring.
Research: Basic research on immune responses and cell biology.

How Does Immunophenotyping Work?

The procedure typically begins with the collection of a blood sample, bone marrow aspirate, or tissue biopsy. The isolated cells are then incubated with fluorescence-labeled antibodies that bind specifically to certain surface antigens. In the flow cytometer, the labeled cells are analyzed one by one:

A laser beam strikes each cell, exciting the fluorescent dyes attached to the antibodies.
Sensors detect the emitted fluorescence as well as the forward and side scatter of light.
This data reveals which surface markers are present on each cell, allowing precise classification by cell type.

Modern instruments can simultaneously measure dozens of markers on thousands of cells per second, enabling rapid and highly detailed analysis of complex cell populations.

Clinical Significance in Blood Cancer Diagnosis

Immunophenotyping plays a central role in the diagnosis and classification of leukemias and lymphomas. By examining which combinations of CD markers are expressed by abnormal cells, clinicians can not only confirm a diagnosis but also gain critical information about prognosis and the most appropriate treatment strategy. For example, it allows precise differentiation between B-cell leukemia, T-cell leukemia, and NK-cell leukemia.

Immunophenotyping in HIV Infection

In patients living with HIV, immunophenotyping is routinely used to determine the count of CD4-positive T helper cells. This value is a key indicator of immune status and guides decisions about initiating antiretroviral therapy. A CD4 count below 200 cells per microliter of blood significantly increases the risk of serious opportunistic infections.

Advantages and Limitations

The main advantages of immunophenotyping include:

High specificity and sensitivity in cell identification
Simultaneous analysis of multiple markers across large numbers of cells
Rapid results, even from small sample volumes
Quantitative data on immune cell populations

Key limitations include:

High costs for equipment and reagents
Requirement for specialized, trained laboratory personnel
Results must always be interpreted within the broader clinical context

References

Bain, B. J., Bates, I., Laffan, M. A. (Eds.): Dacie and Lewis Practical Haematology. 12th edition. Elsevier, 2016.
Craig, F. E., Foon, K. A.: Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;111(8):3941–3967. PubMed PMID: 18198345.
World Health Organization (WHO): Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edition. IARC Press, Lyon, 2017.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.